CN105748824A - Origin preserving and blood replenishing paste and preparation technology thereof - Google Patents
Origin preserving and blood replenishing paste and preparation technology thereof Download PDFInfo
- Publication number
- CN105748824A CN105748824A CN201610204358.5A CN201610204358A CN105748824A CN 105748824 A CN105748824 A CN 105748824A CN 201610204358 A CN201610204358 A CN 201610204358A CN 105748824 A CN105748824 A CN 105748824A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- radix
- corii asini
- colla corii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Abstract
The invention provides origin preserving and blood replenishing paste and a preparation technology thereof, and relates to the technical field of traditional Chinese medicine.The origin preserving and blood replenishing paste is prepared from radix ginseng rubra, milkvetch roots, common yam rhizomes, Chinese wolfberry fruit, fructus jujubae, cortex cinnamomi, liquorice roots, colla corii asini, rock candies and fructus crataegi.The origin preserving and blood replenishing paste is has the significant effect when the paste is used for treating aplastic anemia syndrome, qi and blood deficiency anemia, leucopenia and a qi-deficiency and fatigable subhealth syndrome, can enhance the body immune function, improve blood circulation and be beneficial for human body health and is simple in preparation technology, the effective ingredients can be retained in the production process, and the product stability is good.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of guarantor's unit's hematinic ointment and processing technology thereof.
Background technology
The blood deficiency of traditional Chinese medical science indication, namely in modern medicine, the erythrocyte number in unit volume blood and hemoglobin content reduce, the anemia of many reasons such as including the anemia caused by iron deficiency anemia, hemorrhagic anemia, hemolytic anemia, antianemia factor shortage and aplastic anemia.The traditional Chinese medical science is referred to as blood deficiency.Its reason is a lot, as lost blood, drinking and eating irregularly, after being ill body empty etc. can wasting QI-blood, and cause deficiency of spleen and stomach, it is impossible to caused by biochemical QI and blood.Clinical main manifestations is that shallow complexion, lip be pale, dizziness and tinnitus, sleepy weak, palpitation and short breath, insomnia, blood erythrocyte sum and hemoglobin reduction.This disease sickness rate clinically is significantly high, such as puerperal, postoperative, after being ill, no matter in rural area or city, all has substantial amounts of patient, is a kind of commonly encountered diseases.
For the Therapeutic Principle of blood deficiency, when to enrich blood, but note QI invigorating, because QI invigorating can hemopoietic simultaneously.And primary and secondary that is insufficiency of the spleen and that suffer from a deficiency of the kidney must be distinguished, the method giving spleen reinforcing and the kidney invigorating respectively, to strengthen the former of QI and blood biochemistry.Deficiency of both QI and blood, clinical manifestation is pale complexion, dizziness and blurred vision, palpitation and short breath, tiredness, and method for the treatment of is invigorating qi and benefiting blood, and the side of representative has decoction of ten powerful tonics to add and subtract, Radix Angelicae Sinensis, the Radix Astragali, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Rehmanniae Preparata, Radix Glycyrrhizae Preparata, Fructus Jujubae.Plus-minus, palpitation and insomnia, add ripe Semen Ziziphi Spinosae, Fructus Schisandrae Chinensis.Syndrome of deficiency of both heart and spleen.Clinical manifestation had palpitation, Mental fatigue, lack of appetite, abdominal distention, loose stool, tongue is burst weak pulse.Deficiency-weakness of spleen-QI, hemopoietic is not enough, or has under one's command and have no right, and outside blood oozing from the body openings or subcuta neous tissue arteries and veins, all may result in blood deficiency.Deficiency of heart-blood, is difficult gasification, then temper is also empty, and both often interact, or is syndrome of deficiency of both heart and spleen.Deficiency of heart-blood, the heart is become homeless foster, then cardiopalmus；Deficiency of spleen-QI, transporting is lost strong, therefore lack of appetite, abdominal distention, loose stool.QI and blood deficiency, functional activity is gone down, therefore spiritlessness and weakness, pale tongue, thready and weak pulse, it is all the disease of insufficiency of vital energy and blood.Therapeutic Method, vigorate qi and replenish the blood, invigorating spleen and nourishing heart, the side of representative is GUIXIN soup, has Radix Ginseng, the Radix Astragali, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Poria cum Radix Pini, Radix Polygalae, Arillus Longan, Semen Ziziphi Spinosae, Radix Glycyrrhizae Preparata, Rhizoma Zingiberis Recens, Fructus Jujubae.Syndrome of yin deficiency of liver and kidney, clinical manifestation had palpitation, tinnitus, dizziness, dysphoria with smothery sensation, xerostomia, method for the treatment of nourishing the liver and kidney, side's medicine can use Fructus Ligustri Lucidi, Herba Ecliptae, Radix Rehmanniae Preparata, baked polygonum capitatum, Fructus Lycii, Carapax Et Plastrum Testudinis (processed), Magnetitum (calcined), Radix Angelicae Sinensis, the Radix Paeoniae Alba.Plus-minus, subcutaneous hemorrhage, add Colla Corii Asini, Herba Agrimoniae.Current Chinese patent medicine, such as SHENGXUE WAN, has Cornu Cervi Pantotrichum, Cortex Phellodendri, Rhizoma Dioscoreae, the Rhizoma Atractylodis Macrocephalae (stir-fry), Ramulus Mori, Semen Lablab Album (stir-fry), Placenta Hominis；Bolus of ten powerful tonics, medicine has Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae Preparata, Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Radix Rehmanniae Preparata, the Radix Astragali, Cortex Cinnamomi.Radix Polygoni Multiflori pill, medicine has baked polygonum capitatum, Radix Rehmanniae, Radix Achyranthis Bidentatae, Fructus Mori, Fructus Ligustri Lucidi, sudden and violent Fructus seu radix camptothecae acuminatae (Fructus Camptothecae Acuminatae), Folium Mori, Semen Sesami Nigrum, Semen Cuscutae, Fructus Rosae Laevigatae, and grass, Fructus Psoraleae, Flos Lonicerae etc. are signed in Xi.Other still has DANGGUI YANGXUE WAN.
The above medicine, prescription is complicated, complicated component, and except cost height, in process of production, wayward effective ingredient, product stability can also be difficult to control to, and is the main bugbear of the modernization of Chinese medicine.
Summary of the invention
(1) solve the technical problem that
Not enough for prior art, the present invention provides a kind of and protects unit's hematinic ointment and processing technology thereof, composition is simple, processing technology is simple, in process of production, it is possible to retain effective ingredient, product stability can be good, for treating the subhealth state disease of aplastic amenia disease, the anemic disorders of insufficiency of vital energy and blood, leukopenia disease and the weak fatiguability of the deficiency of vital energy, there is significant effect.
(2) technical scheme
For realizing object above, the present invention is achieved by the following technical programs:
A kind of guarantor unit hematinic ointment, is made up of the raw material of following weight portion: Radix Ginseng Rubra 150-200 part, Radix Astragali 400-500 part, Rhizoma Dioscoreae 400-500 part, Fructus Lycii 260-350 part, Fructus Jujubae 260-350 part, Cortex Cinnamomi 70-120 part, Radix Glycyrrhizae 150-200 part, Colla Corii Asini 260-350 part, crystal sugar 260-350 part, Fructus Crataegi 150-200 part.
Preferably, described unit's hematinic ointment of protecting is made up of the raw material of following weight portion: Radix Ginseng Rubra 160-190 part, Radix Astragali 420-470 part, Rhizoma Dioscoreae 420-470 part, Fructus Lycii 280-330 part, Fructus Jujubae 270-320 part, Cortex Cinnamomi 80-110 part, Radix Glycyrrhizae 160-190 part, Colla Corii Asini 290-310 part, crystal sugar 280-320 part, Fructus Crataegi 160-190 part.
Preferably, described unit's hematinic ointment of protecting is made up of the raw material of following weight portion: Radix Ginseng Rubra 180 parts, the Radix Astragali 450 parts, Rhizoma Dioscoreae 450 parts, Fructus Lycii 300 parts, 300 parts of Fructus Jujubae, Cortex Cinnamomi 90 parts, 180 parts of Radix Glycyrrhizae, 300 parts of Colla Corii Asini, 300 parts of crystal sugar, Fructus Crataegi 180 parts.
A kind of preparation method protecting unit's hematinic ointment, comprises the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing are put into and decoct in still, add water soak at room temperature 0.5-2h, soaks and terminates post-heating decoction still to 80-110 DEG C, and decocting time is 1-3h, refilter, collect filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct 2-3 time, filter, collection liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 70-90 DEG C of refining, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, and 50-90 DEG C of heated and stirred receives cream.
Preferably, the soak time of described step S2 Traditional Chinese drug mixture is 1h, soaks and terminates post-heating decoction still to 100 DEG C, and decocting time is 1.5h, and described step S3 decocts 3 times repeatedly.
A kind of guarantor unit hematinic ointment, described guarantor unit hematinic ointment is ointment for oral administration.
A kind of guarantor unit hematinic ointment, described guarantor unit hematinic ointment is used for treating aplastic amenia disease, the anemic disorders of insufficiency of vital energy and blood, leukopenia disease and subhealth state disease.
(3) beneficial effect
The present invention provides a kind of and protects unit's hematinic ointment and processing technology thereof, the present invention protects unit's hematinic ointment for treating the subhealth state disease of aplastic amenia disease, the anemic disorders of insufficiency of vital energy and blood, leukopenia disease and the weak fatiguability of the deficiency of vital energy, there is significant effect, can enhancing human body immunity function, improve blood circulation, contribute to health；
The present invention provides a kind of unit's hematinic ointment of protecting to increase unit, improving eyesight for QI invigorating, and with functions of blood enriching and yin nourishing of promoting the production of body fluid is moisturized, loosening bowel to relieve constipation, vitamin deficiency, dyspepsia and endocrine disturbance, have the effect of skin maintenance, smoothing wrinkle speckle dispelling simultaneously；
The composition that the present invention protects unit's hematinic ointment is simple, and processing technology is simple, in process of production, it is possible to retain effective ingredient, and product stability can be good.
Detailed description of the invention
For making the purpose of the embodiment of the present invention, technical scheme and advantage clearly, below in conjunction with the embodiment of the present invention, the technical scheme in the embodiment of the present invention is clearly and completely described, it is clear that, described embodiment is a part of embodiment of the present invention, rather than whole embodiments.Based on the embodiment in the present invention, the every other embodiment that those of ordinary skill in the art obtain under not making creative work premise, broadly fall into the scope of protection of the invention.
Embodiment 1:
The present embodiment protects unit's hematinic ointment, is made up of the raw material of following weight portion: Radix Ginseng Rubra 150-200 part, Radix Astragali 400-500 part, Rhizoma Dioscoreae 400-500 part, Fructus Lycii 260-350 part, Fructus Jujubae 260-350 part, Cortex Cinnamomi 70-120 part, Radix Glycyrrhizae 150-200 part, Colla Corii Asini 260-350 part, crystal sugar 260-350 part, Fructus Crataegi 150-200 part.
Preparation method, comprises the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing are put into and decoct in still, add water soak at room temperature 0.5-2h, soaks and terminates post-heating decoction still to 80-110 DEG C, and decocting time is 1-3h, refilter, collect filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct 2-3 time, filter, collection liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 70-90 DEG C of refining, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, and 50-90 DEG C of heated and stirred receives cream.
Embodiment 2:
The present embodiment protects unit's hematinic ointment, is made up of the raw material of following weight portion: Radix Ginseng Rubra 150 parts, the Radix Astragali 400 parts, Rhizoma Dioscoreae 400 parts, Fructus Lycii 260 parts, 260 parts of Fructus Jujubae, Cortex Cinnamomi 70 parts, 150 parts of Radix Glycyrrhizae, 260 parts of Colla Corii Asini, 260 parts of crystal sugar, Fructus Crataegi 150 parts.
Preparation method, comprises the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing being put into and decocted in still, add water soak at room temperature 0.5h, soaks and terminates post-heating and decoct still to 80 DEG C, and decocting time is 1h, refilters, and collects filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct 2 times, filter, collect liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 70 DEG C of refinings, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, 50 DEG C of heated and stirred receipts cream.
Embodiment 3:
The present embodiment protects unit's hematinic ointment, is made up of the raw material of following weight portion: Radix Ginseng Rubra 200 parts, the Radix Astragali 500 parts, Rhizoma Dioscoreae 500 parts, Fructus Lycii 350 parts, 350 parts of Fructus Jujubae, Cortex Cinnamomi 120 parts, 200 parts of Radix Glycyrrhizae, 350 parts of Colla Corii Asini, 350 parts of crystal sugar, Fructus Crataegi 200 parts.
Preparation method, comprises the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing being put into and decocted in still, add water soak at room temperature 2h, soaks and terminates post-heating and decoct still to 110 DEG C, and decocting time is 3h, refilters, and collects filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct 3 times, filter, collect liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 90 DEG C of refinings, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, 90 DEG C of heated and stirred receipts cream.
Embodiment 4:
The present embodiment protects unit's hematinic ointment, is made up of the raw material of following weight portion: Radix Ginseng Rubra 180 parts, the Radix Astragali 450 parts, Rhizoma Dioscoreae 450 parts, Fructus Lycii 300 parts, 300 parts of Fructus Jujubae, Cortex Cinnamomi 90 parts, 180 parts of Radix Glycyrrhizae, 300 parts of Colla Corii Asini, 300 parts of crystal sugar, Fructus Crataegi 180 parts.
Preparation method, comprises the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing being put into and decocted in still, add water soak at room temperature 1h, soaks and terminates post-heating and decoct still to 100 DEG C, and decocting time is 1.5h, refilters, and collects filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct 3 times, filter, collect liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 80 DEG C of refinings, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, 70 DEG C of heated and stirred receipts cream.
Embodiment 5:
The present embodiment protects unit's hematinic ointment, is made up of the raw material of following weight portion: Radix Ginseng Rubra 160 parts, the Radix Astragali 420 parts, Rhizoma Dioscoreae 420 parts, Fructus Lycii 280 parts, 270 parts of Fructus Jujubae, Cortex Cinnamomi 80 parts, 160 parts of Radix Glycyrrhizae, 290 parts of Colla Corii Asini, 280 parts of crystal sugar, Fructus Crataegi 160 parts.
Preparation method, comprises the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing being put into and decocted in still, add water soak at room temperature 1h, soaks and terminates post-heating and decoct still to 90 DEG C, and decocting time is 2h, refilters, and collects filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct 3 times, filter, collect liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 75 DEG C of refinings, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, 60 DEG C of heated and stirred receipts cream.
Embodiment 6:
The present embodiment protects unit's hematinic ointment, is made up of the raw material of following weight portion: Radix Ginseng Rubra 190 parts, the Radix Astragali 470 parts, Rhizoma Dioscoreae 470 parts, Fructus Lycii 330 parts, 320 parts of Fructus Jujubae, Cortex Cinnamomi 110 parts, 190 parts of Radix Glycyrrhizae, 310 parts of Colla Corii Asini, 320 parts of crystal sugar, Fructus Crataegi 190 parts.
Preparation method, comprises the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing are put into and decoct in still, add water soak at room temperature 1.5h, soaks and terminates post-heating decoction still to 80-110 DEG C, and decocting time is 2.5h, refilter, collect filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct-3 times, filter, collect liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 85 DEG C of refinings, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, 85 DEG C of heated and stirred receipts cream.
Clinical data:
The present invention protects unit's hematinic ointment, uses 200 examples through clinical patient, 50 example Patients with Aplastic Anemia, the Anemic patients of 50 example insufficiency of vital energy and bloods, 50 example leukopenia patients, the 50 weak fatigable sub-health populations of the example deficiency of vital energy.
Exact efficacy, does not find that patient has untoward reaction and anaphylaxis.
Therapeutic Method: patient is administered orally, one time 20 grams, each 1 time sooner or later.Calculating treatment time according to conditions of patients weight, the Anemic patients of insufficiency of vital energy and blood, leukopenia patient, the weak fatigable sub-health population of the deficiency of vital energy are taken and can be clearly better for about 8 weeks, and Patients with Aplastic Anemia serve on about 12 weeks symptoms and can improve.
Curative effect determinate standard: (1) fully recovers: transference cure, without exception；(2) effective: substantially to disappear, feature is improved substantially；(3) take a turn for the better: symptom alleviates to some extent, and feature makes moderate progress；(4) invalid: symptom and feature are all without improving.
Therapeutic outcome: effective 35 examples of Patients with Aplastic Anemia, take a turn for the better 10 examples, invalid 5 examples；Effective 42 examples of Anemic patients of insufficiency of vital energy and blood, take a turn for the better 5 examples, invalid 3 examples；Effective 40 examples of leukopenia patient, take a turn for the better 6 examples, invalid 4 examples；Effective 47 examples of the weak fatigable sub-health population of the deficiency of vital energy, take a turn for the better 2 examples, invalid 1 example；
Clinical case is illustrated:
Zhang, man, 28 years old, working occurrences in human life, patient's readme, because staying up late for a long time, working and resting irregular, patient always feels that the whole province is unable, drowsy, working is unable to pull oneself together, being the weak fatigable sub-health population of the typical deficiency of vital energy after diagnosing, take the made unit's hematinic ointment of protecting of the present invention after 6 weeks, energy is full, go to work full of vigour, do not recur so far.
Tight certain, female, 45 years old.Diagnosis is the anemia of insufficiency of vital energy and blood, takes the made unit's hematinic ointment of protecting of the present invention after 6 weeks, and symptom is clearly better, and when using by 9 weeks, all diseases disappear, and follow up a case by regular visits to, without recurrence.
Field, man, 7 years old, on August 20th, 2013 examined, and diagnosed as aplastic anemia, took the made unit's hematinic ointment of protecting of the present invention after 8 weeks, and dizziness is clearly better, and after 12 weeks, Anemia takes a turn for the better.
Wang, female, 52 years old, on March 25th, 2012 examined, and diagnosed leukopenia, took the made unit's hematinic ointment of protecting of the present invention after 8 weeks, and symptom is clearly better.
It should be noted that, in this article, the relational terms of such as first and second or the like is used merely to separate an entity or operation with another entity or operating space, and not necessarily requires or imply the relation that there is any this reality between these entities or operation or sequentially.And, term " includes ", " comprising " or its any other variant are intended to comprising of nonexcludability, so that include the process of a series of key element, method, article or equipment not only include those key elements, but also include other key elements being not expressly set out, or also include the key element intrinsic for this process, method, article or equipment.When there is no more restriction, statement " including ... " key element limited, it is not excluded that there is also other identical element in including the process of described key element, method, article or equipment.
Above example is only in order to illustrate technical scheme, it is not intended to limit, although the present invention being described in detail with reference to previous embodiment, it will be understood by those within the art that: the technical scheme described in foregoing embodiments still can be modified by it, or wherein portion of techniques feature is carried out equivalent replacement；And these amendments or replacement, do not make the essence of appropriate technical solution depart from the spirit and scope of various embodiments of the present invention technical scheme.
Claims (7)
1. protect unit's hematinic ointment for one kind, it is characterized in that, be made up of the raw material of following weight portion: Radix Ginseng Rubra 150-200 part, Radix Astragali 400-500 part, Rhizoma Dioscoreae 400-500 part, Fructus Lycii 260-350 part, Fructus Jujubae 260-350 part, Cortex Cinnamomi 70-120 part, Radix Glycyrrhizae 150-200 part, Colla Corii Asini 260-350 part, crystal sugar 260-350 part, Fructus Crataegi 150-200 part.
2. guarantor unit according to claim 1 hematinic ointment, it is characterized in that, be made up of the raw material of following weight portion: Radix Ginseng Rubra 160-190 part, Radix Astragali 420-470 part, Rhizoma Dioscoreae 420-470 part, Fructus Lycii 280-330 part, Fructus Jujubae 270-320 part, Cortex Cinnamomi 80-110 part, Radix Glycyrrhizae 160-190 part, Colla Corii Asini 290-310 part, crystal sugar 280-320 part, Fructus Crataegi 160-190 part.
3. guarantor unit according to claim 1 hematinic ointment, it is characterized in that, be made up of the raw material of following weight portion: Radix Ginseng Rubra 180 parts, the Radix Astragali 450 parts, Rhizoma Dioscoreae 450 parts, Fructus Lycii 300 parts, 300 parts of Fructus Jujubae, Cortex Cinnamomi 90 parts, 180 parts of Radix Glycyrrhizae, 300 parts of Colla Corii Asini, 300 parts of crystal sugar, Fructus Crataegi 180 parts.
4. the preparation method protecting unit's hematinic ointment, it is characterised in that comprise the following steps:
S1, weigh each raw material according to weight portion, first Fructus Jujubae is cleaned, dry, enucleation, standby；
S2, Radix Ginseng Rubra, the Radix Astragali, Rhizoma Dioscoreae, Fructus Lycii, Fructus Jujubae, Cortex Cinnamomi, Radix Glycyrrhizae, Colla Corii Asini, Fructus Crataegi mixing are put into and decoct in still, add water soak at room temperature 0.5-2h, soaks and terminates post-heating decoction still to 80-110 DEG C, and decocting time is 1-3h, refilter, collect filtrate A and filtering residue；
S3, by step S2 collect filtering residue repeatedly decoct 2-3 time, filter, collection liquor B；
S4, container standing overnight is put in step S1 and the step S2 filtrate prepared mixing, collect supernatant, filter 80 mesh sieves, obtain liquor C standby；
S5, crystal sugar heating 70-90 DEG C of refining, then Colla Corii Asini molten processed, the Colla Corii Asini after the crystal sugar after refining, molten being processed is blended into liquor C jointly, and 50-90 DEG C of heated and stirred receives cream.
5. the preparation method protecting unit's hematinic ointment according to claim 4, it is characterised in that the soak time of described step S2 Traditional Chinese drug mixture is 1h, soaks and terminates post-heating decoction still to 100 DEG C, and decocting time is 1.5h, and described step S3 decocts 3 times repeatedly.
6. protect unit's hematinic ointment for one kind, it is characterised in that described guarantor unit hematinic ointment is ointment for oral administration.
7. protect unit's hematinic ointment for one kind, it is characterised in that described guarantor unit hematinic ointment is used for treating aplastic amenia disease, the anemic disorders of insufficiency of vital energy and blood, leukopenia disease and subhealth state disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610204358.5A CN105748824A (en) | 2016-04-01 | 2016-04-01 | Origin preserving and blood replenishing paste and preparation technology thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610204358.5A CN105748824A (en) | 2016-04-01 | 2016-04-01 | Origin preserving and blood replenishing paste and preparation technology thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105748824A true CN105748824A (en) | 2016-07-13 |
Family
ID=56346047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610204358.5A Pending CN105748824A (en) | 2016-04-01 | 2016-04-01 | Origin preserving and blood replenishing paste and preparation technology thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105748824A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106615411A (en) * | 2016-09-23 | 2017-05-10 | 天津保元堂生物科技有限公司 | Origin preserving and liver nourishing tea and method for preparing same |
| CN107213258A (en) * | 2016-12-27 | 2017-09-29 | 林妙丽 | A kind of pure Chinese medicine maintaining vigor-curing paste and preparation method thereof |
| CN109601993A (en) * | 2017-09-30 | 2019-04-12 | 时传彬 | One kind is tonified Qi of the kidney nourishing blood and tranquilization nourishing-paste and its preparation process |
| CN109939215A (en) * | 2019-05-09 | 2019-06-28 | 参之道(通化)生物科技有限公司 | A kind of red ginseng drink and preparation method thereof |
| CN114146140A (en) * | 2020-09-08 | 2022-03-08 | 陈涵 | Medicine formula for treating leukemia |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163067A (en) * | 1996-06-23 | 1997-10-29 | 张秀文 | Compound donkey-hide gelatin health food |
| CN1535700A (en) * | 2003-04-08 | 2004-10-13 | 李金明 | Blood-supplementing medicine composition |
| CN102823857A (en) * | 2012-08-30 | 2012-12-19 | 吉林天强制药有限公司 | Ginseng donkey-hide gelatin healthcare food |
-
2016
- 2016-04-01 CN CN201610204358.5A patent/CN105748824A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163067A (en) * | 1996-06-23 | 1997-10-29 | 张秀文 | Compound donkey-hide gelatin health food |
| CN1535700A (en) * | 2003-04-08 | 2004-10-13 | 李金明 | Blood-supplementing medicine composition |
| CN102823857A (en) * | 2012-08-30 | 2012-12-19 | 吉林天强制药有限公司 | Ginseng donkey-hide gelatin healthcare food |
Non-Patent Citations (1)
| Title |
|---|
| MAOXUANLIU: "Hematopoietic effects and mechanisms of Fufang e jiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice", 《JOURNAL OFETHNOPHARMACOLOGY》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106615411A (en) * | 2016-09-23 | 2017-05-10 | 天津保元堂生物科技有限公司 | Origin preserving and liver nourishing tea and method for preparing same |
| CN107213258A (en) * | 2016-12-27 | 2017-09-29 | 林妙丽 | A kind of pure Chinese medicine maintaining vigor-curing paste and preparation method thereof |
| CN109601993A (en) * | 2017-09-30 | 2019-04-12 | 时传彬 | One kind is tonified Qi of the kidney nourishing blood and tranquilization nourishing-paste and its preparation process |
| CN109939215A (en) * | 2019-05-09 | 2019-06-28 | 参之道(通化)生物科技有限公司 | A kind of red ginseng drink and preparation method thereof |
| CN114146140A (en) * | 2020-09-08 | 2022-03-08 | 陈涵 | Medicine formula for treating leukemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266520B (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN100518807C (en) | A Medicine for treatment of ascites due to cirrhosis | |
| CN105748824A (en) | Origin preserving and blood replenishing paste and preparation technology thereof | |
| CN105560827B (en) | A kind of ointment and preparation method thereof for perimenopausal syndrome conditioning | |
| CN101199738B (en) | Medicament for treating cough and gasp disease | |
| CN102872363B (en) | Chinese medicinal oral liquid for treating anemia | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN104510970A (en) | Use of traditional Chinese medicine preparation in preparation of drug for treatment of habitual abortion | |
| CN105963547A (en) | Health medicinal liquor capable of treating insomnia and preparation method of health medicinal liquor | |
| CN101199796B (en) | External antidiarrhoeal medicament, preparing method and function thereof | |
| CN103099998A (en) | Traditional Chinese medicine decoction for treating diabetic nephropathy | |
| CN105079551A (en) | Traditional Chinese medicine composition for treating edema | |
| CN106492138A (en) | The Chinese medicine preparation for the treatment of insomnia | |
| CN106138668A (en) | A kind of Chinese medicine composition treating COPD and preparation method thereof | |
| CN1287827C (en) | Blood-supplementing traditional Chinese medicine preparation and its production method | |
| CN102423435A (en) | Chinese medicine for treating infantile malnutrition and preparation method thereof | |
| CN109833398A (en) | The composition and preparation method thereof for treating diabetes | |
| CN103933280A (en) | Traditional Chinese medicine composition for treating PCI (percutanecus coronary intervention) postoperative angina of phlegm-obstructing heart vessel type coronary heart disease and application thereof | |
| CN106377621A (en) | Preparation method of traditional Chinese medicine composition for treating premature graying of beards and hair | |
| CN104721580A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN111773286A (en) | Traditional Chinese medicine preparation for treating anemia and preparation method thereof | |
| CN104888136A (en) | Traditional Chinese medicine composition for treatment of insomnia | |
| CN103041156A (en) | Drug for treating elderly intractable insomnia and preparation method of drug | |
| CN102100853B (en) | Traditional Chinese medicine for treating gout and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |